Microsoft Feared OverReliance on OpenAI Trial Testimony Reveals Foghorn Therapeutics FHTX Slides 168 as Selling Pressure Mounts 20260514 Cerebras Surges 109 on Debut Ushering in Wave of AI MegaIPOs